Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties

참고문헌 (82)

1. "Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol", 4-acetamidophe(l), pp.410~1
2. "the worldwide exploration of nature for novel antitumor agents", pp.156~63 (1997)
3. "A class of semi-essential food components their role in human nutrition", the flavo(ids), pp.117~91
4. "Flavonol and flavone intakes in US health professionals", pp.1414~20 (2002)
5. "Dietary intake and bioavailability of polyphenols", pp.8~ (2000)
6. "Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells", pp.2425~32 (2004)
7. "Resveratrol enhances the expression of non-steroidal anti-inflammatory drug- activated gene by increasing the expression of p53", pp.425~1 34 (2002)
8. "3'-diindolylmethane induce expression of NAG-1 in a p53-independent manner", indole-3-carbi(l and 3), pp.63~9 (2005)
9. "is induced by genistein through the expression of p53 in colorectal cancer cells", pp.747~1 53
10. "a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic", antipyretic drugs, 2002, 13926~3 31[DOI]
11. "Prostaglandin synthase 2", pp.125~40 (1996)
12. "Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis", pp.1247~55 (2000), Pincus T
13. "Renal effects of COX-2-selective inhibitors", pp.1~15 (2001)
14. "Flavonoids and related compounds as inhibition of arachidonic acid peroxidation", pp.627~39
15. "Modification of platelet function and arachidonic acid metabolism by bioflavonoids", pp.1525~30
16. "The flavonoids of Tanacetum parthenium and T", pp.417~23 (1999)
17. "3 beta-p-hydroxybenzoyldehydrotumulosic acid from Poria cocos", nu(ura y), pp.1357~60 (1999)
18. "Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells", pp.~10 (2003)
19. "Mechanism-based in vitro screening of potential cancer chemopreventive agents", pp.523 163~524 72 (2003)
20. "inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells", pp.1039~44 (2004)
21. "Cancer chemopreventive activity of resveratrol", pp.65~77
22. "Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester- treated human mammary epithelial cells", pp.21875~82 (1998)
23. "Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives effects on cytosolic phospholipase A", pp.1671~9 (2004)
24. "Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure", pp.959~63 (2000)
25. "Suppression of cyclooxygenase-2 expression of skin fibroblasts by wogonin a plant flavone from Scutellaria radix", pp.59~66 (2005)
26. "Effects of sophoraflavanone G a prenylated flavonoid from Sophora flavescens on cyclooxygenase-2 and in vivo inflammatory response", pp.329~35 (2002)
27. "Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives Relationship to antioxidant activity and to iron ion-reducing ability", pp.1673~81
28. "Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF", pp.106~10 (1997)
29. "Analytical and pharmacological investigation of Ocotea bullata", pp.219~30 (2000)
30. "Selective inhibition of platelet lipoxygenase by baicalein", pp.1090~5
31. "Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid", pp.1185~91 (2001)
32. "Dual inhibitors of cyclooxygenase and 5-lipoxygenase A new avenue in anti-inflammatory therapy", pp.1433~8 (2001)
33. "Selectivity of neutrophil 5-lipoxygenase and cyclo- oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids", pp.787~92
34. "Phospholipase A2--a mediator between proximal and distal effectors of inflammation", pp.143~6
35. "The expanding superfamily of phospholipase A2 enzymes", pp.1~19 (2000)
36. "Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism", mattelia(ml), pp.2765~74
37. "Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide", 14-eicosatetray(rdihydroguaiaretic acid ic acid and quercetin), pp.214~7
38. "Selective inhibition of group II phospholipase A2 by quercetin", pp.573~82
39. "Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice", pp.~8
40. "a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti- inflammatory activity", pp.733~40 (1997)
41. "Specific physiological roles of cytosolic phospholipase A2 as defined by gene knockouts", pp.139~48 (2000)
42. "orphans with ligands and functions", pp.159~66 (1997)
43. "modes of action and human relevance", pp.655~780 (2003)
44. "regulators of gene expression in vascular cells", pp.1168~78 (2004)
45. "and expression of the human PPARgamma gene" (1997)
46. "a distinct PPARgamma mRNA subtype", pp.3 55~60 (1998)
47. "Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor", tonto(z p), pp.237~41 (1997)
48. "Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas", pp.1281~7 (2002)
49. "Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines", pp.2243~51 (2002)
50. "PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines", pp.82~6 (1998)
51. "The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation", pp.79~82 (1998)
52. "Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone", pp.1188~93
53. "The PPARalpha-leukotriene B4 pathway to inflammation control", pp.39~43 (1996)
54. "Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha", pp.51~8 (2004)
55. "Effect of green tea polyphenols on the genes with atherosclerotic potential", pp.177~9 (2004), Shukla AR
56. "Inhibition of TNFalpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF- kappaB activation in A549 cells", pp.105~10 (2002)
57. "Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264", pp.7~ (1998)
58. "Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin and quercetin pentaacetate in RAW 264", pp.7 537~48 (2001)
59. "In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds", pp.390~7 (1998)
60. "Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264", pp.7 941~9 (1999)
61. -Gingerol inhibits nitric oxide synthesis in activated J774, , 2003, 3427~37
62. "-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB", pp.465~72 (1997)
63. "Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol", pp.673~80 (1999)
64. "Suppression of inducible nitric oxide production by indole and isothiocyanate derivatives from Brassica plants in stimulated macrophages", pp.696~700 (2003)
65. "Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation", pp.1445~57 (2000)
66. "Cancer chemoprevention with dietary phytochemicals", pp.768~80 (2003)
67. "Inhibition of the transcription factor NF-kappa B by sesquiterpene lactones from Podachaenium eminens", pp.591~5 (2000)
68. "inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells", pp.1680~4 (1997)
69. "In vivo quercitrin anti-inflammatory effect involves release of quercetin which inhibits inflammation through down-regulation of the NF-kappaB pathway", pp.584~92 (2005)
70. "prevents inflammatory stress in organotypic hippocampal slice cultures", pp.111~20 (2003)
71. "an extract of red wine inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF- & kappa", pp.840~1 (2005)
72. "Indole-3-carbinol suppresses NF-{kappa}B and I{kappa}B{alpha} kinase activation causing inhibition of expression of NF- {kappa}B-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells", pp.641~9 (2005)
73. "Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities", pp.901~8 (2001)
74. "Dual function of nonsteroidal anti-inflammatory drugs inhibition of cyclooxygenase and induction of NSAID- activated gene", pp.1126~31 (2002)
75. "is a divergent member of the TGF- beta superfamily", pp.11514~1 9 (1997)
76. "Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression", pp.20127~35 (2000)
77. "Cloning and characterization of a novel member of the transforming growth factor-beta", bone morphogenetic protein family, 1998, 13760~7
78. "Characterization of the rat and human genes of growth", differentiation factor-15, pp.1999[DOI]
79. "novel placental bone morphogenetic protein", pp.40~4 (1997)
80. "Lineage- restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines", pp.310~23 (1999)
81. "Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1 which results in the up-regulation of NAG-1", pp.356~64 (2005)
82. "is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway", pp.109~14 (2000)

관련 논문AI추천